Enhanced phosphorylation of p53 by ATN in response to DNA damage

被引:1683
作者
Banin, S
Moyal, L
Shieh, SY
Taya, Y
Anderson, CW
Chessa, L
Smorodinsky, NI
Prives, C
Reiss, Y
Shiloh, Y [1 ]
Ziv, Y
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Ramat Aviv, Israel
[2] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[3] Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, Tokyo 104, Japan
[4] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA
[5] Univ Rome La Sapienza, Dipartimento Med Sperimentale, I-00161 Rome, Italy
[6] Tel Aviv Univ, George S Wise Fac Life Sci, Hybridoma Unit, IL-69978 Ramat Aviv, Israel
[7] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Ramat Aviv, Israel
关键词
D O I
10.1126/science.281.5383.1674
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ATM protein, encoded by the gene responsible for the human genetic disorder ataxia telangiectasia (A-T), regulates several cellular responses to DNA breaks. ATM shares a phosphoinositide 3-kinase-related domain with several proteins, some of them protein kinases. A wortmannin-sensitive protein kinase activity was associated with endogenous or recombinant ATM and was abolished by structural ATM mutations. In vitro substrates included the translation repressor PHAS-I and the p53 protein. ATM phosphorylated p53 in vitro on a single residue, serine-15, which is phosphorylated in vivo in response to DNA damage. This activity was markedly enhanced within minutes after treatment of cells with a radiomimetic drug; the total amount of ATM remained unchanged. Various damage-induced responses may be activated by enhancement of the protein kinase activity of ATM.
引用
收藏
页码:1674 / 1677
页数:4
相关论文
共 32 条
  • [1] BANIN S, UNPUB
  • [2] Atm-deficient mice: A paradigm of ataxia telangiectasia
    Barlow, C
    Hirotsune, S
    Paylor, R
    Liyanage, M
    Eckhaus, M
    Collins, F
    Shiloh, Y
    Crawley, JN
    Ried, T
    Tagle, D
    WynshawBoris, A
    [J]. CELL, 1996, 86 (01) : 159 - 171
  • [3] CONTROL OF P70 S6 KINASE BY KINASE-ACTIVITY OF FRAP IN-VIVO
    BROWN, EJ
    BEAL, PA
    KEITH, CT
    CHEN, J
    SHIN, TB
    SCHREIBER, SL
    [J]. NATURE, 1995, 377 (6548) : 441 - 446
  • [4] Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin
    Brunn, GJ
    Hudson, CC
    Sekulic, A
    Williams, JM
    Hosoi, H
    Houghton, PJ
    Lawrence, JC
    Abraham, RT
    [J]. SCIENCE, 1997, 277 (5322) : 99 - 101
  • [5] Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002
    Brunn, GJ
    Williams, J
    Sabers, C
    Wiederrecht, G
    Lawrence, JC
    Abraham, RT
    [J]. EMBO JOURNAL, 1996, 15 (19) : 5256 - 5267
  • [6] FISCELLA M, 1993, ONCOGENE, V8, P1519
  • [7] Genotype-phenotype relationships in ataxia-telangiectasia and variants
    Gilad, S
    Chessa, L
    Khosravi, R
    Russell, P
    Galanty, Y
    Piane, M
    Gatti, RA
    Jorgensen, TJ
    Shiloh, Y
    Bar-Shira, A
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) : 551 - 561
  • [8] Predominance of null mutations in ataxia-telangiectasia
    Gilad, S
    Khosravi, R
    Shkedy, D
    Uziel, T
    Ziv, Y
    Savitsky, K
    Rotman, G
    Smith, S
    Chessa, L
    Jorgensen, TJ
    Harnik, R
    Frydman, M
    Sanal, O
    Portnoi, S
    Goldwicz, Z
    Jaspers, NGJ
    Gatti, RA
    Lenoir, G
    Lavin, MF
    Tatsumi, K
    Wegner, RD
    Shiloh, Y
    BarShira, A
    [J]. HUMAN MOLECULAR GENETICS, 1996, 5 (04) : 433 - 439
  • [9] GOLDBERG IH, 1995, ENEDIYNE ANTIBIOTICS, P327
  • [10] DNA-DEPENDENT PROTEIN-KINASE CATALYTIC SUBUNIT - A RELATIVE OF PHOSPHATIDYLINOSITOL 3-KINASE AND THE ATAXIA-TELANGIECTASIA GENE-PRODUCT
    HARTLEY, KO
    GELL, D
    SMITH, GCM
    ZHANG, H
    DIVECHA, N
    CONNELLY, MA
    ADMON, A
    LEESMILLER, SP
    ANDERSON, CW
    JACKSON, SP
    [J]. CELL, 1995, 82 (05) : 849 - 856